Coronavirus – current medical and social problem

Coronaviruses can be divided into two groups due to pathogenicity. The first group causes mild upper respiratory tract infections. The second group includes highly pathogenic coronaviruses, which are the cause of severe pneumonia. In December 2019, the emergence of a new 2019-nCoV coronavirus was reported in the human population, which caused a pandemic. Cases of pneumonia have been reported in patients. Complications included: acute respiratory distress syndrome, anaemia, acute myocardial injury, secondary infections and in severe cases - death of patients. Viral factors and host immune responses were important in the development of infection. The course of the disease also depended on: initial viral load in the respiratory tract, comorbidities and the age of patients. Younger people experienced milder symptoms, and older people had more severe disease. Diabetes, hypertension, cardiovascular disease and renal failure were the most frequently mentioned comorbidities. The therapeutic problems concerned the need to develop effective CoV treatment regimens. Late diagnosis is often the cause of a complex situation that requires intervention in intensive care units. There are still no approved antiviral drugs and vaccines to prevent SARS-CoV infection. One of the therapeutic solutions is to change the purpose of various approved medicines used in other diseases. Another problem is the transmission of infection, which occurs between people as a result in close and direct contact. Rules for protection against infection have been introduced. Personal protective equipment has been used: gloves, aprons, protective masks and glasses. In addition, the transmission of the infection in indirect contact with contaminated objects is of great importance. Monitoring the epidemiological situation and providing timely information is very important to ensure the safety of the public during and after the pandemic. The purpose of this article is to present the characteristics of the new 2019-nCoV coronavirus and its ability to multiply in the human body. Pathogenic types of coronaviruses, current infection, symptoms, diagnostic methods, treatment and infection transmission, and psychological effects of quarantine are discussed.

Abstract licence: CC BY-NC

1. 8.

   Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease · 2018

2. 9.

   Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2 · 2018

3. 11.
   Corrected

   Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis · 2018

4. 13.

   Bats and Coronaviruses · 2019

5. 14.

   Bat Coronaviruses in China · 2019

6. 18.
   Expression of concern

   Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR · 2020

7. 19.

   Return of the Coronavirus: 2019-nCoV · 2020

8. 20.

   A pneumonia outbreak associated with a new coronavirus of probable bat origin · 2020

9. 25.

   Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 · 2020

10. 26.

    Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection · 2020

26 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.